Pregabalin for the treatment of generalized anxiety disorder: an update
David S Baldwin,1–3 Khalil Ajel,3 Vasilios G Masdrakis,4 Magda Nowak,1 Rizwan Rafiq31Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; 2Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Afr...
Enregistré dans:
Auteurs principaux: | Baldwin DS, Ajel K, Masdrakis VG, Nowak M, Rafiq R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/69dadd853ece42a99a4e5f92f6a1d795 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Duloxetine in the treatment of generalized anxiety disorder
par: Trevor R Norman, et autres
Publié: (2009) -
Duloxetine for the treatment of generalized anxiety disorder: a review
par: Ahsan Y Khan, et autres
Publié: (2008) -
New treatment options in the management of fibromyalgia: role of pregabalin
par: Grazyna Zareba
Publié: (2008) -
Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
par: Levitan MN, et autres
Publié: (2015) -
Pregabalin for the management of partial epilepsy
par: Philippe Ryvlin, et autres
Publié: (2008)